Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792742876> ?p ?o ?g. }
- W2792742876 endingPage "30" @default.
- W2792742876 startingPage "23" @default.
- W2792742876 abstract "To verify the long-term efficacy of resective surgery, we created a classification system in which strictly defined patterns of postoperative seizure emergence are incorporated as basic components and the seizure states throughout the entire follow-up period are assessed comprehensively. In our system, Class I has three subclasses (A–C); subclasses A and B are identical to Engel I-A and I-B, respectively. Subclass C comprises patients whose disabling seizures remit within the first 2 years postoperatively. Patients in Class II have only 1–3 days with disabling seizures throughout follow-up after the first 2 years. Patients in Class III have a maximum of 3 seizure days annually, and those in Class IV have ≥4 seizure days annually after the first 2 years. Classes II–IV each have 2 subclasses (A and B): subclass A, late recurrence (i.e., the first seizure occurs after 2 years postoperatively); and subclass B, early recurrence (i.e., first seizure within 2 years). In 646 patients who underwent resective surgery (temporal lobe resection, 74.6%) and were followed for at least 8 years (mean, 14.6 years), we analyzed three patterns of postoperative seizures: early remission, late recurrence, and occasional seizures. In addition, we investigated the differences between the long-term seizure outcomes of the cohort as determined according to our system and the Engel scale. Overall, 52.9% of the cohort experienced at least one disabling seizure postoperatively throughout the follow-up period; in 1/3 of these patients, the first seizure occurred after 2 years. In 73.8% of the 80 patients who manifested the running-down phenomenon, seizure remission occurred within the first 2 years. In addition, 36.7% of the 283 patients who had disabling seizures after 2 years experienced only 1–3 seizure days. Engel Class I-C included about 30% of the patients who had ≥4 seizure days after 2 years. The long-term seizure outcomes, determined according to our system, were: Class I, 56.2% (C, 9.1%) of the overall cohort; Class II, 16.1% (A, 11.0%); and Class III/IV, 27.7% (A, 6.6%). Our system clarifies the actual effect of resective surgery more precisely than the Engel scale and thus may be useful for comparing outcomes between different surgical procedures or for identifying potential risk factors predicting unfavorable outcome." @default.
- W2792742876 created "2018-03-29" @default.
- W2792742876 creator A5009185180 @default.
- W2792742876 creator A5014256354 @default.
- W2792742876 creator A5030598955 @default.
- W2792742876 creator A5039128309 @default.
- W2792742876 creator A5051936587 @default.
- W2792742876 creator A5065912853 @default.
- W2792742876 creator A5082610939 @default.
- W2792742876 date "2018-03-01" @default.
- W2792742876 modified "2023-10-18" @default.
- W2792742876 title "A classification system for verifying the long-term efficacy of resective surgery for drug-resistant seizures" @default.
- W2792742876 cites W1528314503 @default.
- W2792742876 cites W1767469754 @default.
- W2792742876 cites W1769992009 @default.
- W2792742876 cites W1968769427 @default.
- W2792742876 cites W1975304462 @default.
- W2792742876 cites W1975615336 @default.
- W2792742876 cites W1988280863 @default.
- W2792742876 cites W1996777847 @default.
- W2792742876 cites W1998180306 @default.
- W2792742876 cites W2000237277 @default.
- W2792742876 cites W2013385033 @default.
- W2792742876 cites W2016511769 @default.
- W2792742876 cites W2023261684 @default.
- W2792742876 cites W2025124682 @default.
- W2792742876 cites W2025334070 @default.
- W2792742876 cites W2044257801 @default.
- W2792742876 cites W2054083058 @default.
- W2792742876 cites W2054232755 @default.
- W2792742876 cites W2056533870 @default.
- W2792742876 cites W2063422351 @default.
- W2792742876 cites W2066045621 @default.
- W2792742876 cites W2068765556 @default.
- W2792742876 cites W2083548652 @default.
- W2792742876 cites W2091352756 @default.
- W2792742876 cites W2112463945 @default.
- W2792742876 cites W2117378831 @default.
- W2792742876 cites W2121709831 @default.
- W2792742876 cites W2122247828 @default.
- W2792742876 cites W2126727507 @default.
- W2792742876 cites W4245932665 @default.
- W2792742876 doi "https://doi.org/10.1016/j.eplepsyres.2018.01.019" @default.
- W2792742876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29414384" @default.
- W2792742876 hasPublicationYear "2018" @default.
- W2792742876 type Work @default.
- W2792742876 sameAs 2792742876 @default.
- W2792742876 citedByCount "4" @default.
- W2792742876 countsByYear W27927428762019 @default.
- W2792742876 countsByYear W27927428762023 @default.
- W2792742876 crossrefType "journal-article" @default.
- W2792742876 hasAuthorship W2792742876A5009185180 @default.
- W2792742876 hasAuthorship W2792742876A5014256354 @default.
- W2792742876 hasAuthorship W2792742876A5030598955 @default.
- W2792742876 hasAuthorship W2792742876A5039128309 @default.
- W2792742876 hasAuthorship W2792742876A5051936587 @default.
- W2792742876 hasAuthorship W2792742876A5065912853 @default.
- W2792742876 hasAuthorship W2792742876A5082610939 @default.
- W2792742876 hasConcept C118552586 @default.
- W2792742876 hasConcept C126322002 @default.
- W2792742876 hasConcept C141071460 @default.
- W2792742876 hasConcept C159654299 @default.
- W2792742876 hasConcept C187212893 @default.
- W2792742876 hasConcept C203014093 @default.
- W2792742876 hasConcept C2776194381 @default.
- W2792742876 hasConcept C2778186239 @default.
- W2792742876 hasConcept C2780803581 @default.
- W2792742876 hasConcept C2781099131 @default.
- W2792742876 hasConcept C2910833928 @default.
- W2792742876 hasConcept C42219234 @default.
- W2792742876 hasConcept C71924100 @default.
- W2792742876 hasConcept C72563966 @default.
- W2792742876 hasConceptScore W2792742876C118552586 @default.
- W2792742876 hasConceptScore W2792742876C126322002 @default.
- W2792742876 hasConceptScore W2792742876C141071460 @default.
- W2792742876 hasConceptScore W2792742876C159654299 @default.
- W2792742876 hasConceptScore W2792742876C187212893 @default.
- W2792742876 hasConceptScore W2792742876C203014093 @default.
- W2792742876 hasConceptScore W2792742876C2776194381 @default.
- W2792742876 hasConceptScore W2792742876C2778186239 @default.
- W2792742876 hasConceptScore W2792742876C2780803581 @default.
- W2792742876 hasConceptScore W2792742876C2781099131 @default.
- W2792742876 hasConceptScore W2792742876C2910833928 @default.
- W2792742876 hasConceptScore W2792742876C42219234 @default.
- W2792742876 hasConceptScore W2792742876C71924100 @default.
- W2792742876 hasConceptScore W2792742876C72563966 @default.
- W2792742876 hasLocation W27927428761 @default.
- W2792742876 hasLocation W27927428762 @default.
- W2792742876 hasOpenAccess W2792742876 @default.
- W2792742876 hasPrimaryLocation W27927428761 @default.
- W2792742876 hasRelatedWork W1991623258 @default.
- W2792742876 hasRelatedWork W2007118736 @default.
- W2792742876 hasRelatedWork W2097377975 @default.
- W2792742876 hasRelatedWork W2105669039 @default.
- W2792742876 hasRelatedWork W2145083537 @default.
- W2792742876 hasRelatedWork W2195355925 @default.
- W2792742876 hasRelatedWork W2738356303 @default.
- W2792742876 hasRelatedWork W2899870277 @default.